Welcome to NovioSense The Tear Glucose Company

Hello and welcome to NovioSense the tear glucose sensor company. Since 2012 we have been developing our non-invasive glucose sensor platform from concept through to clinical validation. In 2019 we completed our third clinical trial of the NovioSense Glucose Sensor together with Hageland Medical Centre in The Hague in The Netherlands. Our clinical trial results were published in the Journal of Diabetes Science and Technology the leading Journal for the publication of new glucose sensor technology and clinical trials. You can read the published results of two of our clinical trials here and here.

In 2020 the company was acquired by WMC group LLC. You can view our old website here on the Wayback Machine.

NovioSense in 2021

Time has changed

Today NovioSense is leveraging its know how and intellectual property to develop new deep technology solutions for some of todays most demanding healthcare and fine chemicals challenges.

Medical Devices

Leveraging our experience in developing Class II and III medical devices we have the capability and know how to develop wearable medical sensors and accessory devices for a range of todays medical needs

Custom Coatings

Through our sensor business we have developed three families of hydrophilic coatings suitable for use in or on the body as well as in some of the most challenging non-medical applications.

Joint Development

Experience in developing technologies with some of the worlds leading knowledge institutes, universities and public companies means we understand how to work with you to deliver custom applications of our technology platforms.

Developing Technology for your Product with NovioSense

email: info@noviosense.com